Source link : https://www.newshealth.biz/health-news/multiagent-adjuvant-therapy-ups-pancreatic-cancer-survival/
TOPLINE: Adjuvant combination leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin (FOLFIRINOX) and other multiagent chemotherapy regimens boost overall survival (OS) in patients with resected pancreatic adenocarcinoma after preoperative FOLFIRINOX. Single-agent adjuvant chemotherapy shows no significant survival benefit. METHODOLOGY: Researchers conducted a retrospective cohort study across 48 centers in 20 countries from 2010 to 2018 of […]
Author : News Health
Publish date : 2025-01-24 06:51:59
Copyright for syndicated content belongs to the linked Source.
inHealth